Thanks Kens, it's very clear that Acadia cannot hold back Neuren from developing indications outside of Acadia's NNZ2591 Field, which is reiterated more than once in the agreement. The decks are cleared, lets go!
- Forums
- ASX - By Stock
- NEU
- Pipeline-in-a-drug
NEU
neuren pharmaceuticals limited
Add to My Watchlist
5.71%
!
$14.07

Pipeline-in-a-drug, page-48
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.07 |
Change
0.760(5.71%) |
Mkt cap ! $1.730B |
Open | High | Low | Value | Volume |
$13.50 | $14.09 | $12.96 | $4.626M | 338.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 277 | $14.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.08 | 8 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14 | 14.040 |
6 | 342 | 14.030 |
8 | 867 | 14.020 |
8 | 1148 | 14.010 |
9 | 9861 | 14.000 |
Price($) | Vol. | No. |
---|---|---|
14.050 | 37 | 1 |
14.060 | 533 | 5 |
14.070 | 1456 | 6 |
14.080 | 1371 | 4 |
14.090 | 1379 | 6 |
Last trade - 12.25pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online